Skip to content

Detection rate of adenomas and serrated lesions between anesthesia and non-anesthesia colonoscopy

Detection rate of adenomas and serrated lesions between anesthesia and non-anesthesia colonoscopy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085658
Enrollment
Unknown
Registered
2024-06-14
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Anesthesia Assistance (AA) group:None
non-Anesthesia Assistance (non-AA) group:None

Sponsors

Lishui Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ?18 = Age = 80; ?Patients who undergo colonoscopy for the first or regular time; ?Willing to sign an informed consent form; ?Willing to complete the subject satisfaction questionnaire and willing to accept subsequent follow-up.

Exclusion criteria

Exclusion criteria: ?Refusing to sign an informed consent form; ?Patients who have been previously diagnosed with colorectal adenoma or serrated lesions but have not undergone any treatment; ?History of colorectal resection; ?Patients with inflammatory bowel disease, colorectal malignant tumors, colorectal metastases, lymphoma, massive ascites, or renal failure; ?Patients undergoing colonoscopy due to unconventional examination reasons such as bleeding or rectal foreign bodies; ?Individuals who are unable to adapt to sedation and anesthesia, including those who have difficulty controlling blood pressure, blood sugar, heart rate, or have a history of allergies to anesthetic drugs; ?Patients who are not suitable for biopsy due to coagulation dysfunction or other reasons.

Design outcomes

Primary

MeasureTime frame
adenoma detection rate (ADR);sessile serrated lesion detection rate (SSL-DR);

Secondary

MeasureTime frame
Subject satisfaction;Total inspection cost;Adverse event occurrence rate;

Countries

China

Contacts

Public ContactYe Bin

Lishui Central Hospital

408252097@qq.com+86 138 5707 8092

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026